Hydroxyurea‐mediated release of nitric oxide in myeloproliferative neoplasms patients: Effects on platelet–leukocyte interaction

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|10|1125-1130

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.10, 2015-10, pp. : 1125-1130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 152-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent Advances in Platelet-Polymorphonuclear Leukocyte Interaction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 1999-09 ,pp. : 41-49

Karger

Access to resources Recommend Favorite

Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy

By  

Acta Haematologica, Vol. 120, Iss. 4, 2009-01 ,pp. : 195-198

Karger

Access to resources Recommend Favorite

Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 506-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impaired Flow-Mediated Vasodilation in vivo and Reduced Shear-Induced Platelet Reactivity in vitro in Response to Nitric Oxide in Prothrombotic, Stroke-Prone Spontaneously Hypertensive Rats

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 4, 2009-12 ,pp. : 184-189

Karger

Access to resources Recommend Favorite